Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Covid-19 pandemic has significantly upset clinical development.
More than 1,000 clinical trials have been disrupted by the ongoing pandemic, primarily due to issues with enrolment and recruitment, according to GlobalData.
With many countries implementing nationwide lockdowns, it has become virtually impossible for patients to actually visit sites for monitoring.
To ease this burden, many companies have attempted to adapt and salvage their clinical trials by virtualising them, as this allows for remote monitoring of patients and a reduced need for participants to risk moving around during a pandemic.